Urban Indians Develop Fatty Liver at Lower Body Weights Than Rural Peers

Oct 20, 2026 By Esther Okello

Urban Indians are developing fatty liver disease at body weights that would be considered healthy by international standards. The condition, non-alcoholic fatty liver disease (NAFLD), is increasingly diagnosed in lean city dwellers, while rural peers with similar or higher body mass indices (BMI) often remain free of the disease. This paradox challenges conventional wisdom and has significant implications for screening and prevention in India.

The Lean Liver Paradox in Indian Cities

In cities like Delhi and Chennai, hepatologists report a growing number of NAFLD cases in patients with a BMI below 25, the threshold for overweight according to WHO guidelines. These patients often have normal weight but carry excess fat around the abdomen, a characteristic of the South Asian phenotype. Rural populations, despite sometimes higher BMI, show lower prevalence of fatty liver, suggesting that factors beyond body weight are at play.

Dr. S. K. Sarin, a leading hepatologist in Delhi, has documented this trend in clinic-based surveys. He notes that urban lifestyles, characterised by sedentary work and calorie-dense diets, contribute to visceral fat accumulation even in lean individuals. The rural environment, with more physical activity and less processed food, appears to offer some protection, though this shield is weakening as urbanisation spreads.

The clinical puzzle is compounded by the fact that standard BMI cutoffs were derived from Western populations. For South Asians, a BMI of 23 may already indicate increased risk. This mismatch means many at-risk individuals are missed by routine screening that relies solely on BMI.

What the Ultrasound Clinics Are Finding

Ultrasound clinics in metropolitan hospitals are detecting fatty liver incidentally in patients undergoing scans for unrelated reasons. Clinic-based series from Delhi hospitals suggest that a meaningful share of adults with a BMI under 25 show evidence of hepatic steatosis on ultrasound, with reported figures in the range of a quarter to a third of those scanned. Comparable rural cohorts in Haryana have generally shown lower prevalence in the same BMI band, though the gap appears to be narrowing year on year. These are convenience samples, not population surveys, and the selection bias runs in obvious directions: people who reach a metropolitan scan suite are not representative of the district they came from.

Waist-to-height ratio (WHtR) has emerged as a better predictor of NAFLD than BMI in Indian populations. A WHtR above 0.5, regardless of BMI, signals increased metabolic risk. This simple measure, requiring only a tape measure, could be a game-changer for primary care settings where ultrasound is unavailable.

Researchers at Chennai's Madras Diabetes Research Foundation have shown that visceral fat, measured by MRI, correlates strongly with fatty liver even in non-obese individuals. Their work highlights the need for targeted screening strategies that go beyond weight.

Why Body Weight Misleads in India

The South Asian phenotype is characterised by a tendency to store fat viscerally rather than subcutaneously. This 'thin-fat' phenotype means that even lean individuals can have high levels of dangerous intra-abdominal fat. Insulin resistance, a hallmark of type 2 diabetes, is common in this group and contributes to fat accumulation in the liver.

Genetic factors and early-life nutrition also play a role. The thrifty phenotype hypothesis suggests that individuals exposed to undernutrition in utero or early childhood are more susceptible to metabolic diseases when later exposed to calorie-rich diets. This may explain why urban migrants from rural areas are particularly vulnerable.

Dr. Anoop Misra, a diabetologist in New Delhi, has long argued that BMI cutoffs for Indians should be lowered to 23 for overweight and 25 for obesity. His research shows that at these lower thresholds, the risk of diabetes and fatty liver rises sharply. Despite these recommendations, many clinical guidelines still use international cutoffs.

The practical consequence is a screening gap that runs in both directions. A lean patient with a normal BMI is reassured and sent home; a mildly overweight patient is told to lose weight without anyone measuring the waist or ordering a liver panel. Neither pathway catches the person whose liver is already accumulating fat. The test that would catch them is cheap and unglamorous, and it is rarely the one that gets ordered.

A Patient's Journey Through Urban Stress

Consider the case of a 35-year-old software engineer in Bengaluru who was diagnosed with fatty liver during a routine health check. With a BMI of 23.5, he was not overweight by standard charts. His waist circumference, however, was 36 inches, indicating central obesity. He worked long hours, commuted two hours daily, and relied on refined carbohydrates and sugary drinks for quick energy.

The diagnosis came as a shock. He had always considered himself healthy. The stigma of a 'fat' disease at normal weight made him reluctant to discuss it with friends. His doctor advised weight loss, but he was already lean. The advice missed the mark: he needed to reduce visceral fat through dietary changes and increased physical activity, not just lose weight.

His journey reflects the challenges faced by many urban Indians. The stress of city life, sleep deprivation, and lack of time for exercise create an environment conducive to metabolic dysfunction. Addressing these factors requires a shift in focus from weight to metabolic health.

Rural Life as an Imperfect Shield

Rural populations in India have historically had lower rates of NAFLD, but this advantage is eroding. A study in rural Punjab found that obesity rates have risen sharply over the past decade, driven by mechanisation of agriculture and increased consumption of processed foods. The prevalence of fatty liver in rural areas is now approaching urban levels.

Underdiagnosis remains a major problem. Primary health centres often lack ultrasound machines and trained personnel. Liver enzymes like ALT are not routinely checked. As a result, many rural patients are diagnosed only when they develop advanced liver disease.

Urbanisation's slow creep into villages brings with it the same risk factors: sedentary jobs, motorised transport, and calorie-dense diets. The rural shield is not a permanent barrier but a temporary reprieve.

The Cost of Missing It Early

Fatty liver is often treated as a benign finding, a line on an ultrasound report that prompts a vague instruction to eat better. That framing understates what happens over ten or twenty years. A proportion of people with NAFLD progress to steatohepatitis, then to fibrosis, and eventually to cirrhosis or liver cancer. The progression is slow and largely silent, which is precisely why the cheap early measures matter. By the time symptoms appear, the window for lifestyle-based reversal has usually closed.

Treatment options remain limited. There is no approved drug for NAFLD in India, and the pipeline of candidates in late-stage trials has repeatedly disappointed. Weight loss of roughly 5 to 10 percent of body weight is the intervention with the strongest evidence behind it, but that target translates awkwardly for a patient who is already lean. For them the goal is compositional: less visceral fat, more muscle, better insulin sensitivity, with the scale moving very little. Explaining that to a patient who expects a number to fall is one of the harder conversations in primary care.

Cost shapes the diagnostic pathway too. An ultrasound in a private metropolitan lab is affordable for the middle class but out of reach for many patients at public facilities, where queues for imaging run long and referrals are rationed. Transient elastography, which measures liver stiffness and gives a better sense of fibrosis, is concentrated in tertiary centres and corporate hospitals. The result is that the patients at highest risk of progression are often the ones least likely to be staged accurately.

Practical Steps for Lean Fatty Liver

If you are an urban Indian with a normal BMI but central obesity, consider these steps to protect your liver health:

  • Ask your doctor to measure your waist circumference and calculate your waist-to-height ratio. A ratio above 0.5 warrants further evaluation.
  • Request liver function tests, including ALT and AST, and an ultrasound if you have risk factors such as diabetes, high triglycerides, or a family history of fatty liver.
  • Cut back on sugary drinks and refined grains like white rice and maida. Replace them with whole grains, legumes, and vegetables.
  • Aim for at least 150 minutes of moderate-intensity activity per week, such as brisk walking or cycling. Breaking up long periods of sitting is also beneficial.
  • Discuss your family history with your doctor. A history of diabetes or heart disease increases your risk and may justify earlier screening.

These steps are not a substitute for professional medical advice. If you suspect you have fatty liver, consult a healthcare provider for personalised guidance.

Recommend Posts
Health

Zambia's Cholera Vaccine Stockpile Runs Dry as Cases Climb

By Min Park/Oct 20, 2026

Zambia's cholera resurgence emptied a global vaccine stockpile. Experts disagree on whether reactive mass campaigns work as well as water and sanitation investment.
Health

Asthma Care Follows the Coverage Formulary, Not the Spirometer

By Raphael Andriamanjato/Oct 20, 2026

How payer formularies and prior authorization shape asthma treatment more than spirometry, and what clinicians can do within those constraints.
Health

Occupational Asthma Screening Lags in Vietnam's Garment Factories

By Min Park/Oct 20, 2026

Vietnam's garment factories expose workers to cotton and synthetic dusts that cause occupational asthma, yet routine screening and referral pathways remain absent.
Health

India's Fatty Liver Cases Follow the Waistline, Not the Alcohol

By Elena Vargas/Oct 20, 2026

Fatty liver disease in India is increasingly driven by central obesity and insulin resistance, not alcohol. Kerala clinics show why waist measurement matters more than BMI.
Health

Asthma Inhalers Cost the Same While Hospital Admissions Diverge by District

By Esther Okello/Oct 20, 2026

The same asthma inhaler costs the same everywhere, yet hospital admissions vary several-fold by district. The gap is clinical practice, not drug price.
Health

Urban Indians Develop Fatty Liver at Lower Body Weights Than Rural Peers

By Esther Okello/Oct 20, 2026

Urban Indians develop fatty liver at lower body weights than rural peers. Explore the lean liver paradox, why BMI misleads, and practical steps for diagnosis and care.
Health

Atrial Fibrillation Screening in Rural Kerala Finds Strokes It Cannot Prevent

By Raphael Andriamanjato/Oct 20, 2026

Mobile ECG camps in rural Kerala are finding atrial fibrillation in people who cannot access the anticoagulation that would make detection worthwhile.
Health

Ghana Weighs Herbal Sedatives Against Diazepam for Anxiety Care

By Esther Okello/Oct 20, 2026

Ghana's Mampong herbal clinic treats thousands for anxiety, but without published trial data, clinicians debate whether herbal sedatives can replace diazepam.
Health

Glasgow's Diabetes Divide Starts in the Liver

By Raphael Andriamanjato/Oct 20, 2026

Type 2 diabetes and fatty liver follow Glasgow's wealth gradient. The biology of insulin resistance explains why the same condition damages livers unevenly.
Health

In Brazil's Northeast, Hypertension Diagnoses Arrive After the Stroke

By Elena Vargas/Oct 20, 2026

In Brazil's Northeast, hypertension often goes unnoticed until a stroke brings patients to emergency wards. Surveys and clinicians describe a preventable cascade.
Health

Kenya's Mental Health Fund Leaves Community Clinics Off the Reimbursement List

By Raphael Andriamanjato/Oct 20, 2026

Kenya's Mental Health Fund reimburses only accredited facilities, leaving community clinics and their patients to pay out of pocket for depression and anxiety care.
Health

Malaria in Infants Treated Late at Both Ends of the Income Scale

By Raphael Andriamanjato/Oct 20, 2026

Malaria in infants is a race against the parasite's multiplication. Wealth doesn't always buy speed, and poverty adds hours that cost lives. A mechanism explainer.
Health

Community Health Workers Catch Newborn Sepsis in Malawi Where Labs Cannot

By Min Park/Oct 20, 2026

In Malawi, community health workers use simple checklists to spot newborn sepsis where blood cultures are rare. Evidence shows promise, but referral delays and stockouts limit impact.
Health

Ugandan Newborns Die of Sepsis While First-Line Antibiotics Miss the Organism

By Raphael Andriamanjato/Oct 20, 2026

In Uganda, WHO first-line antibiotics often fail against the bacteria causing neonatal sepsis. Clinicians and researchers disagree on whether to change empiric therapy.
Health

Depression Treatment Guidelines Stall at Nigeria's Primary Care Gate

By Elena Vargas/Oct 20, 2026

Nigeria's depression guidelines rarely reach primary clinics. Payer rules, out-of-pocket costs and thin supervision keep treatment stuck at the gate.
Health

Why Hospitals Keep Treating Resistant Infections With Older Drugs

By Raphael Andriamanjato/Oct 20, 2026

Older antibiotics like colistin and fosfomycin are back in wards facing resistant infections. Experts disagree on dosing, combinations, and how much kidney harm is acceptable.
Health

Drug-Resistant Tuberculosis Care Splits Between Cape Town and Its Townships

By Elena Vargas/Oct 20, 2026

Cape Town's drug-resistant TB burden exposes stark contrasts in care between wealthy suburbs and townships, where delays, stockouts, and stigma undermine outcomes.
Health

Depression Screening Scores Higher Than the Treatment It Refers To

By Esther Okello/Oct 20, 2026

Depression screening tools like the PHQ-9 are fast, validated and widely mandated. The referral pathways they feed into are slower, narrower and rarely measured.
Health

Neonatal Jaundice Blocks Breastfeeding in Villages More Than in Cities

By Esther Okello/Oct 20, 2026

Neonatal jaundice is common everywhere, but rural newborns miss the bilirubin peak because discharge, follow-up and phototherapy all sit further away.
Health

Asthma Guidelines Diverge on Rescue Inhaler Reliance Across Europe

By Elena Vargas/Oct 20, 2026

European asthma guidelines disagree on whether frequent rescue inhaler use is a warning sign or a rational habit, and the trial evidence behind each position is thinner than it looks.